219 related articles for article (PubMed ID: 26462050)
1. A novel assay revealed that ribonucleotide reductase is functionally important for interstrand DNA crosslink repair.
Fujii N; Evison BJ; Actis ML; Inoue A
Bioorg Med Chem; 2015 Nov; 23(21):6912-21. PubMed ID: 26462050
[TBL] [Abstract][Full Text] [Related]
2. mTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancer.
Tian L; Chen C; Guo Y; Zhang F; Mi J; Feng Q; Lin S; Xi N; Tian J; Yu L; Chen Y; Cao M; Lai C; Fan J; Zhang Y; Chen G
Neoplasia; 2021 Jul; 23(7):643-652. PubMed ID: 34126361
[TBL] [Abstract][Full Text] [Related]
3. DHS (trans-4,4'-dihydroxystilbene) suppresses DNA replication and tumor growth by inhibiting RRM2 (ribonucleotide reductase regulatory subunit M2).
Chen CW; Li Y; Hu S; Zhou W; Meng Y; Li Z; Zhang Y; Sun J; Bo Z; DePamphilis ML; Yen Y; Han Z; Zhu W
Oncogene; 2019 Mar; 38(13):2364-2379. PubMed ID: 30518875
[TBL] [Abstract][Full Text] [Related]
4. Targeting IGF Perturbs Global Replication through Ribonucleotide Reductase Dysfunction.
Rieunier G; Wu X; Harris LE; Mills JV; Nandakumar A; Colling L; Seraia E; Hatch SB; Ebner DV; Folkes LK; Weyer-Czernilofsky U; Bogenrieder T; Ryan AJ; Macaulay VM
Cancer Res; 2021 Apr; 81(8):2128-2141. PubMed ID: 33509941
[TBL] [Abstract][Full Text] [Related]
5. Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors.
Lin ZP; Belcourt MF; Cory JG; Sartorelli AC
J Biol Chem; 2004 Jun; 279(26):27030-8. PubMed ID: 15096505
[TBL] [Abstract][Full Text] [Related]
6. Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samples.
Spanswick VJ; Lowe HL; Newton C; Bingham JP; Bagnobianchi A; Kiakos K; Craddock C; Ledermann JA; Hochhauser D; Hartley JA
BMC Cancer; 2012 Sep; 12():436. PubMed ID: 23020514
[TBL] [Abstract][Full Text] [Related]
7. Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma.
Goss KL; Gordon DJ
Oncotarget; 2016 Sep; 7(39):63003-63019. PubMed ID: 27557498
[TBL] [Abstract][Full Text] [Related]
8. Functional Genomic Screen in Mesothelioma Reveals that Loss of Function of BRCA1-Associated Protein 1 Induces Chemoresistance to Ribonucleotide Reductase Inhibition.
Okonska A; Bühler S; Rao V; Ronner M; Blijlevens M; van der Meulen-Muileman IH; de Menezes RX; Wipplinger M; Oehl K; Smit EF; Weder W; Stahel RA; Penengo L; van Beusechem VW; Felley-Bosco E
Mol Cancer Ther; 2020 Feb; 19(2):552-563. PubMed ID: 31619462
[TBL] [Abstract][Full Text] [Related]
9. The synergistic interaction of gemcitabine and cytosine arabinoside with the ribonucleotide reductase inhibitor triapine is schedule dependent.
Sigmond J; Kamphuis JA; Laan AC; Hoebe EK; Bergman AM; Peters GJ
Biochem Pharmacol; 2007 May; 73(10):1548-57. PubMed ID: 17324380
[TBL] [Abstract][Full Text] [Related]
10. Detection of a new substrate-derived radical during inactivation of ribonucleotide reductase from Escherichia coli by gemcitabine 5'-diphosphate.
van der Donk WA; Yu G; Pérez L; Sanchez RJ; Stubbe J; Samano V; Robins MJ
Biochemistry; 1998 May; 37(18):6419-26. PubMed ID: 9572859
[TBL] [Abstract][Full Text] [Related]
11. Ribonucleotide reductase inhibition improves the symptoms of a Caenorhabditis elegans model of Alzheimer's disease.
Brokate-Llanos AM; Sanchez-Ibañez M; Pérez-Jiménez MM; Monje-Moreno JM; Gómez-Marín C; Caro C; Vivar-Rios C; Moreno-Mateos MA; García-Martín ML; Muñoz MJ; Royo JL
G3 (Bethesda); 2024 May; 14(5):. PubMed ID: 38412549
[TBL] [Abstract][Full Text] [Related]
12. Mechanism for ribonucleotide reductase inactivation by the anticancer drug gemcitabine.
Pereira S; Fernandes PA; Ramos MJ
J Comput Chem; 2004 Jul; 25(10):1286-94. PubMed ID: 15139041
[TBL] [Abstract][Full Text] [Related]
13. Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer.
Bennett CN; Tomlinson CC; Michalowski AM; Chu IM; Luger D; Mittereder LR; Aprelikova O; Shou J; Piwinica-Worms H; Caplen NJ; Hollingshead MG; Green JE
Breast Cancer Res; 2012 Jul; 14(4):R109. PubMed ID: 22812567
[TBL] [Abstract][Full Text] [Related]
14. Insight into the mechanism of inactivation of ribonucleotide reductase by gemcitabine 5'-diphosphate in the presence or absence of reductant.
Artin E; Wang J; Lohman GJ; Yokoyama K; Yu G; Griffin RG; Bar G; Stubbe J
Biochemistry; 2009 Dec; 48(49):11622-9. PubMed ID: 19899770
[TBL] [Abstract][Full Text] [Related]
15. Essential Roles of Ribonucleotide Reductases under DNA Damage and Replication Stresses in Cryptococcus neoformans.
Jung KW; Kwon S; Jung JH; Bahn YS
Microbiol Spectr; 2022 Aug; 10(4):e0104422. PubMed ID: 35736239
[TBL] [Abstract][Full Text] [Related]
16. A functional approach reveals a genetic and physical interaction between ribonucleotide reductase and CHK1 in mammalian cells.
Taricani L; Shanahan F; Malinao MC; Beaumont M; Parry D
PLoS One; 2014; 9(11):e111714. PubMed ID: 25375241
[TBL] [Abstract][Full Text] [Related]
17. Replication stress induced by the ribonucleotide reductase inhibitor guanazole, triapine and gemcitabine in fission yeast.
Alyahya MY; Khan S; Bhadra S; Samuel RE; Xu YJ
FEMS Yeast Res; 2022 Mar; 22(1):. PubMed ID: 35262697
[TBL] [Abstract][Full Text] [Related]
18. Subunit and small-molecule interaction of ribonucleotide reductases via surface plasmon resonance biosensor analyses.
Crona M; Furrer E; Torrents E; Edgell DR; Sjöberg BM
Protein Eng Des Sel; 2010 Aug; 23(8):633-41. PubMed ID: 20534631
[TBL] [Abstract][Full Text] [Related]
19. A Single Conserved Residue Mediates Binding of the Ribonucleotide Reductase Catalytic Subunit RRM1 to RRM2 and Is Essential for Mouse Development.
Specks J; Lecona E; Lopez-Contreras AJ; Fernandez-Capetillo O
Mol Cell Biol; 2015 Sep; 35(17):2910-7. PubMed ID: 26077802
[TBL] [Abstract][Full Text] [Related]
20. Yeast Sml1, a protein inhibitor of ribonucleotide reductase.
Chabes A; Domkin V; Thelander L
J Biol Chem; 1999 Dec; 274(51):36679-83. PubMed ID: 10593972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
